Dr. Alhamadsheh’s talk won the best Moderated Poster Presentation for the Cardiac Amyloidosis

August 27, 2017

Dr. Alhamadsheh’s talk won the best Moderated Poster Presentation for the Cardiac Amyloidosis session at the European Society of Cardiology (ESC) Congress in Barcelona.

Link:https://www.escardio.org/Congresses-%26-Events/ESC-Congress

 

Dr. Alhamadsheh presented our lab work on half-life extension of peptides at the Cambridge Healthtech Institute’s 2017 Peptide Discovery and Development meeting (Cambridge, MA).

http://www.optcongress.com/Peptide-Discovery/

News Highlights of Our Technology for Enhancing in Vivo Half-life of Peptides

Recently, our group developed a novel approach for enhancing the pharmacokinetic properties and in vivo half-life of peptides therapeutics (e.g. insulin). Our approach would potentially decrease dosing frequency and improve patient convenience and compliance which should increase the clinical success rate of therapeutic agents and decrease its production cost. This work was recently published in the prestigious journal Nature Chemical Biology. This paper garnered much attention (Highlighted by Nature Reviews Drug Discovery and Academic Pharmacy Now). It was also highlighted in a number of publications:

1. http://www.fiercebiotechresearch.com/story/neat-trick-guards-peptides-against-early-degradation/2015-11-04
2. https://www.sciencedaily.com/releases/2015/11/151102164102.htm
3. https://www.nsf.gov/news/news_summ.jsp?cntn_id=136935
4. http://sciencebusiness.technewslit.com/?p=28006
5. http://phys.org/news/2015-11-approach-peptides-longer-life.html
6. http://www.innovationessence.com/lifespan-treating-diseases/